CAMP Continuation Study/Phase 2

CAMP 继续研究/第 2 阶段

• 批准号: 6804673
• 负责人: ROBERT S ZEIGER
• 金额: $ 20.02万
• 依托单位: UNIVERSITY OF CALIFORNIA, SAN DIEGO
• 依托单位国家: 美国
• 财政年份: 2003
• 资助国家: 美国
• 起止时间: 2003-09-30 至 2007-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6804673
• 关键词: adolescence (12-20); asthma; body height; child physical development; clinical research; cooperative study; corticosteroids; drug adverse effect; human subject; longitudinal human study; lung development; patient care management; respiratory disorder epidemiology; young adult human (21-34)

The University of California at San Diego (UCSD) and Kaiser Permanente (KP) San Diego have participated as one of the 8 Clinical Centers in the Childhood Asthma Management Program (CAMP) Trial and CAMP Continuation Study (CAMPCS) since contract inception and award in 1991. For CAMP, our site randomized the required 122 children 5-12.years of age with mild to moderate asthma of which 40% were from ethnic minorities. Our research facilities are well equipped and conducive to perform all aspects of CAMPCS/2. The scientific portion of the study is part of the CAMPCS/2 multicenter proposal provided in the Washington University application. We at the UCSD/KP Clinical Center are willing to participate in the additional follow-up requested by this application and our track record as noted above is supportive of our ability to do so.

加利福尼亚大学圣地亚哥分校（UCSD）和Kaiser Permanente（KP）圣地亚哥已成为童年哮喘管理计划（CAMP）试验和营地连续研究（CAMPCS）以来1991年的合同成立和奖励（CAMPCS）的8个临床中心之一，自1991年的合同成立和奖励。营地为camp提供了522名儿童的少数人，从而使年龄为5-12岁。 我们的研究设施设施齐全，有利于执行CAMCC/2的各个方面。该研究的科学部分是华盛顿大学申请中提供的CAMCC/2多中心提案的一部分。我们位于UCSD/KP临床中心愿意参加此应用程序要求的其他后续行动，如上所述，我们的往绩支持我们这样做的能力。